Rare diseases

Tocilizumab on the PBS for GCA

Tocilizumab (Actemra) will be added to the PBS from August 1 for the treatment of giant cell arteritis (GCA). When announcing the new indication, the Federal Health Minister Greg Hunt said subsidised access for the monoclonal antibody would benefit about 852 patients with GCA per year, who would pay over $10,200 per course of treatment. ...

Already a member?

Login to keep reading.

© 2021 the limbic